111 (YI) Asset Writedowns and Impairment (2019)

111 (YI) reported Asset Writedowns and Impairment of $3.1 million for Q3 2019, up 91.5% sequentially from $1.6 million in Q1 2019.

111 (YI) Asset Writedowns and Impairment (2019) Analysis & Trends

111 (YI) has 1 years of Asset Writedowns and Impairment data on file, last reported at $3.1 million in Q3 2019.

For the quarter ending Q3 2019, Asset Writedowns and Impairment changed N/A year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2019 stood at $4.8 million (changed N/A YoY), and the FY2025 full-year result was $258000.0, down 51.59% from the prior year.
Asset Writedowns and Impairment rose to $3.1 million in Q3 2019, from $1.6 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $3.1 million in Q3 2019 to a low of $1.6 million in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Mckesson	105.15 Bn	101.18 Bn	4.04 Bn
2	Cencora	60.58 Bn	58.40 Bn	3.59 Bn
3	Cardinal Health	53.81 Bn	49.87 Bn	2.50 Bn
4	Henry Schein	9.71 Bn	9.57 Bn	1.07 Bn
5	Akso Health	3.28 Bn	3.28 Bn	-
6	111	651.73 Mn	572.63 Mn	23.58 Mn
7	Accendra Health	248.02 Mn	-88.86 Mn	278.03 Mn
8	Edap Tms	230.14 Mn	215.14 Mn	8.15 Mn
9	VitaNova Life Sciences	11.51 Mn	11.01 Mn	316,343.00
10	Cosmos Health	9.57 Mn	7.41 Mn	1.38 Mn

Download Data